Cheese Consumption and Human Microvascular Function

NCT ID: NCT03376555

Last Updated: 2025-05-04

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE1/PHASE2

Total Enrollment

13 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-07-01

Study Completion Date

2021-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Increased dairy intake is associated with improved measures of blood vessel health. Dairy cheese, however, is often high in sodium. Dietary sodium can impair blood vessel function. The researchers examine if and how natural cheese may protect against impairments in blood vessel function caused by sodium. For this study, participants complete four 8-day controlled feeding periods in which they eat cheese (6 oz/day) or no cheese during a low-sodium or high-sodium base-diet. The participants complete baseline experiments while on their normal personal diet and then repeat experiments at the end of each controlled feeding period. In some of our experiments, the researchers use a technique called "microdialysis" (MD). With MD, the researchers perfuse some research drugs into the skin on the forearm through tiny tubing that mimics capillaries. These MD drugs mimic or block substances the body naturally makes to control the small blood vessels in the skin. The drugs remain in nickel-sized areas around the tubing and do not go into the rest of the body. The researchers also use a standard technique called "flow mediated dilation" (FMD) that uses blood pressure cuffs and ultrasound to look at the health of larger blood vessels in the body. FMD includes placing a small tablet of nitroglycerin under the tongue during part of the test.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Subject screening will be performed by the Penn State Clinical Translational Research Center (CTRC) medical staff and will include a physical exam by a clinician, anthropometry, and a chemical and lipid profile, liver and renal function. Participants meet with a registered dietitian to determine their caloric energy requirements and identify food preferences. The interview includes surveying the subject's physical activity over the previous 7 days.

Subjects will undergo baseline microdialysis experiments to examine the function of the blood vessels in the skin microcirculation. Subjects will also go through a baseline assessment of conduit vessel endothelial and vascular smooth muscle function with brachial artery flow-mediated vasodilation (FMD), and sublingual nitroglycerin. Following baseline experiments, subjects participate in 4 controlled feeding periods, each 8 days in duration. The controlled feeding periods are assigned in a randomized order. At the end of each 8-day controlled dietary period, subjects will repeat microdialysis experiments, brachial artery FMD, and responsiveness to sublingual nitroglycerin.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Microvascular Dysfunction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

All subjects participate in 4 diets in randomized order. The diets differ in the amount of sodium and dairy cheese content. Each diet is consumed for 8 days. Minimum washout of 1 week between diets. Baseline experiment is conducted prior to first dietary intervention, and the experiment is repeated after each dietary intervention.
Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Investigator and Outcomes Assessor are masked according to treatment.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Impact of Dairy and Sodium on Microvascular Health

Cross over design with a baseline and 4 dietary interventions

Group Type EXPERIMENTAL

Low sodium no cheese

Intervention Type DIETARY_SUPPLEMENT

Diet contains 1,500 mg sodium per day Diet does not contain dairy cheese 8 days

Low sodium cheese

Intervention Type DIETARY_SUPPLEMENT

Diet contains 1,500 mg sodium per day Diet contains 6 oz dairy cheese per day 8 days

High sodium no cheese

Intervention Type DIETARY_SUPPLEMENT

Diet contains 5,500 mg sodium per day Diet does not contain dairy cheese 8 days

High sodium cheese

Intervention Type DIETARY_SUPPLEMENT

Diet contains 5,500 mg sodium per day Diet contains 6 oz dairy cheese per day 8 days

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Low sodium no cheese

Diet contains 1,500 mg sodium per day Diet does not contain dairy cheese 8 days

Intervention Type DIETARY_SUPPLEMENT

Low sodium cheese

Diet contains 1,500 mg sodium per day Diet contains 6 oz dairy cheese per day 8 days

Intervention Type DIETARY_SUPPLEMENT

High sodium no cheese

Diet contains 5,500 mg sodium per day Diet does not contain dairy cheese 8 days

Intervention Type DIETARY_SUPPLEMENT

High sodium cheese

Diet contains 5,500 mg sodium per day Diet contains 6 oz dairy cheese per day 8 days

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Seated systolic pressure 120-140 mmHg
* Seated diastolic pressure 70-90 mmHg.
* Normoglycemic (HbA1C \<5.7%)

Exclusion Criteria

* Taking pharmacotherapy that alters peripheral vascular control
* Pregnancy
* Breastfeeding
* Females taking contraceptives (pills, patches, shots, etc.) or hormone replacement therapy
* Taking illicit and/or recreational drugs
* Use of nicotine containing-products (e.g. smoking, chewing tobacco, etc.)
* Known allergy to latex or investigative substances
Minimum Eligible Age

55 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Dairy Council

OTHER

Sponsor Role collaborator

Lacy Alexander

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Lacy Alexander

Associate Professor of Kinesiology

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lacy M Alexander, PhD

Role: PRINCIPAL_INVESTIGATOR

Penn State University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Pennsylvania State University

University Park, Pennsylvania, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Alba BK, Stanhewicz AE, Dey P, Bruno RS, Kenney WL, Alexander LM. Controlled Feeding of an 8-d, High-Dairy Cheese Diet Prevents Sodium-Induced Endothelial Dysfunction in the Cutaneous Microcirculation of Healthy, Older Adults through Reductions in Superoxide. J Nutr. 2020 Jan 1;150(1):55-63. doi: 10.1093/jn/nxz205.

Reference Type DERIVED
PMID: 31504721 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol, Statistical Analysis Plan, and Informed Consent Form

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

129552

Identifier Type: OTHER

Identifier Source: secondary_id

STUDY4340

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Dairy Foods and Weight Loss
NCT00858312 COMPLETED NA